Arcutis Biotherapeutics Statistics
Total Valuation
ARQT has a market cap or net worth of $3.23 billion. The enterprise value is $3.10 billion.
| Market Cap | 3.23B |
| Enterprise Value | 3.10B |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARQT has 125.08 million shares outstanding. The number of shares has increased by 2.70% in one year.
| Current Share Class | 125.08M |
| Shares Outstanding | 125.08M |
| Shares Change (YoY) | +2.70% |
| Shares Change (QoQ) | -4.62% |
| Owned by Insiders (%) | 1.63% |
| Owned by Institutions (%) | 84.22% |
| Float | 92.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 86.00 |
| PS Ratio | 7.72 |
| Forward PS | 6.07 |
| PB Ratio | 17.04 |
| P/TBV Ratio | 18.29 |
| P/FCF Ratio | 119.18 |
| P/OCF Ratio | 118.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 567.17, with an EV/FCF ratio of 115.11.
| EV / Earnings | n/a |
| EV / Sales | 7.45 |
| EV / EBITDA | 567.17 |
| EV / EBIT | 964.34 |
| EV / FCF | 115.11 |
Financial Position
The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.60.
| Current Ratio | 2.68 |
| Quick Ratio | 2.26 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 18.24 |
| Debt / FCF | 4.26 |
| Interest Coverage | 0.24 |
Financial Efficiency
Return on equity (ROE) is -1.43% and return on invested capital (ROIC) is 0.72%.
| Return on Equity (ROE) | -1.43% |
| Return on Assets (ROA) | 0.50% |
| Return on Invested Capital (ROIC) | 0.72% |
| Return on Capital Employed (ROCE) | 1.08% |
| Weighted Average Cost of Capital (WACC) | 12.29% |
| Revenue Per Employee | $1.17M |
| Profits Per Employee | -$6,712 |
| Employee Count | 354 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 1.39 |
Taxes
In the past 12 months, ARQT has paid $985,000 in taxes.
| Income Tax | 985,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +87.64% in the last 52 weeks. The beta is 1.48, so ARQT's price volatility has been higher than the market average.
| Beta (5Y) | 1.48 |
| 52-Week Price Change | +87.64% |
| 50-Day Moving Average | 23.15 |
| 200-Day Moving Average | 24.42 |
| Relative Strength Index (RSI) | 58.22 |
| Average Volume (20 Days) | 1,826,406 |
Short Selling Information
The latest short interest is 15.82 million, so 12.65% of the outstanding shares have been sold short.
| Short Interest | 15.82M |
| Short Previous Month | 16.23M |
| Short % of Shares Out | 12.65% |
| Short % of Float | 17.09% |
| Short Ratio (days to cover) | 9.07 |
Income Statement
In the last 12 months, ARQT had revenue of $415.62 million and -$2.38 million in losses. Loss per share was -$0.02.
| Revenue | 415.62M |
| Gross Profit | 377.98M |
| Operating Income | 3.21M |
| Pretax Income | -1.39M |
| Net Income | -2.38M |
| EBITDA | 5.46M |
| EBIT | 3.21M |
| Loss Per Share | -$0.02 |
Balance Sheet
The company has $224.00 million in cash and $114.67 million in debt, with a net cash position of $109.33 million or $0.87 per share.
| Cash & Cash Equivalents | 224.00M |
| Total Debt | 114.67M |
| Net Cash | 109.33M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 189.65M |
| Book Value Per Share | 1.52 |
| Working Capital | 274.85M |
Cash Flow
In the last 12 months, operating cash flow was $26.99 million and capital expenditures -$78,000, giving a free cash flow of $26.92 million.
| Operating Cash Flow | 26.99M |
| Capital Expenditures | -78,000 |
| Depreciation & Amortization | 2.25M |
| Net Borrowing | n/a |
| Free Cash Flow | 26.92M |
| FCF Per Share | $0.22 |
Margins
Gross margin is 90.94%, with operating and profit margins of 0.77% and -0.57%.
| Gross Margin | 90.94% |
| Operating Margin | 0.77% |
| Pretax Margin | -0.33% |
| Profit Margin | -0.57% |
| EBITDA Margin | 1.31% |
| EBIT Margin | 0.77% |
| FCF Margin | 6.48% |
Dividends & Yields
ARQT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.70% |
| Shareholder Yield | -2.70% |
| Earnings Yield | -0.07% |
| FCF Yield | 0.84% |
Analyst Forecast
The average price target for ARQT is $34.63, which is 34.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $34.63 |
| Price Target Difference | 34.23% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 27.71% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARQT has an Altman Z-Score of 3.59 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.59 |
| Piotroski F-Score | 6 |